Status:
COMPLETED
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depression
Eligibility:
All Genders
20-65 years
Phase:
PHASE3
Brief Summary
Phase III long-term safety study of Effexor XR in patients with major depression.
Eligibility Criteria
Inclusion
- Patients who complete the Phase III double-blind study (Protocol Number 0600B1-816)
Exclusion
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00225524
Start Date
September 1 2004
Last Update
May 24 2007
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagoya, Aichi-ken, Japan, 462-0831
2
Nagoya, Aichi-ken, Japan, 467-8602
3
Ichikawa, Chiba, Japan, 272-0034
4
Ichikawa, Chiba, Japan, 272-0827